Rhenman & Partners Asset Management’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
DM
Rhenman & Partners Asset Management's INSP Position: Q1 2026 in Review
Rhenman & Partners Asset Management sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 35,800 shares — an estimated $3.3M sold.
Rhenman & Partners Asset Management first reported a position in INSP in Q4 2021 and held it in 17 quarters. The position peaked at $27.8M in Q4 2024. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- Rhenman & Partners Asset Management reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
- Rhenman & Partners Asset Management sold 35,800 Inspire Medical Systems shares in Q1 2026, an estimated $3.3M.
- Rhenman & Partners Asset Management first reported a position in Inspire Medical Systems in Q4 2021 and held it in 17 quarters.
- Rhenman & Partners Asset Management's Inspire Medical Systems position peaked at $27.8M in Q4 2024.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.